HAZRA, M. A rational pharmacotherapeutic study of comparative safety among topical anti-acne 1% nadifloxacin monotherapy, 0.1% adapalene monotherapy, 0.025% tretinoin monotherapy, 1% nadifloxacin and 0.1% adapalene combination therapy and 1% nadifloxacin and 0.025% tretinoin combination therapy, in mild to moderate acne vulgaris, in tertiary care hospitals. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 8, n. 9, p. 1959–1965, 2019. DOI: 10.18203/2319-2003.ijbcp20193662. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/3627. Acesso em: 21 oct. 2025.